Scientists track Long-Term power of Mom's vaccine to shield babies from dangerous infection
NCT ID NCT06592586
Summary
This study is following women who received an experimental vaccine against Group B Streptococcus (GBS) during a past pregnancy. The main goals are to see how long their immune protection lasts and to check the safety and effectiveness of giving a booster dose if they become pregnant again. The research aims to prevent serious GBS infections, like sepsis and meningitis, in newborns.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus Universitetshospital
RECRUITINGAarhus N, Central Jutland, 8200, Denmark
-
Hvidovre Hospital - Department Of Obstetrics And Gynaecology
ACTIVE_NOT_RECRUITINGCopenhagen, Capital Region, 2650, Denmark
-
Sefako Makgatho Health Sciences University, Medunsa Clinical Research Unit (MeCRU)
RECRUITINGGa-Rankuwa, Gauteng, 0204, South Africa
-
Setshaba Research Centre
RECRUITINGPretoria, Guateng Province, 0152, South Africa
-
Sygehus Lillebælt - Kolding Sygehus
RECRUITINGKolding, Region Syddanmark, 6000, Denmark
-
Wits Reproductive Health and HIV Institute (Wits RHI)
RECRUITINGJohannesburg, Guateng Province, 2001, South Africa
Conditions
Explore the condition pages connected to this study.